RDHL
Redhill Biopharma Ltd. American Depositary Shares (RDHL)
$56
About Redhill Biopharma Ltd. American Depositary Shares (RDHL)
RedHill Biopharma Ltd. develops medicines for gastrointestinal and infectious diseases. It operates through Commercial Operations, and the Research and Development segments. The Commercial Operations segment covers all areas relating to the commercial sales and is being performed by the subsidiary in the U.S. The Research and Development segment includes the study and licensing of therapeutic candidates. Its products include Talicia, Movantik, and Aemcolo. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
Details
Daily high
$2.62
Daily low
$2.48
Price at open
$2.51
52 Week High
$20.28
52 Week Low
$2.47
Market cap
3.3M
Dividend yield
0.00%
Volume
50,583
Avg. volume
188,688
P/E ratio
-.03
Redhill Biopharma Ltd. American Depositary Shares News
Details
Daily high
$2.62
Daily low
$2.48
Price at open
$2.51
52 Week High
$20.28
52 Week Low
$2.47
Market cap
3.3M
Dividend yield
0.00%
Volume
50,583
Avg. volume
188,688
P/E ratio
-.03